As a consequence of these mutations, the BRAF -MEK (Mitogen-activated protein kinase kinase)–ERK (Extracellular signal-regulated kinase)—pathway is constitutively active, leading to uncontrolled cell growth, cell division and subsequently cancer development [1–3]. This evidence concerns the gene BRAF and cancer.